MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
-
Published:2021-08-02
Issue:1
Volume:28
Page:
-
ISSN:1423-0127
-
Container-title:Journal of Biomedical Science
-
language:en
-
Short-container-title:J Biomed Sci
Author:
Li Tong-tong, Mou Jie, Pan Yao-jie, Huo Fu-chun, Du Wen-qi, Liang Jia, Wang Yang, Zhang Lan-sheng, Pei Dong-shengORCID
Abstract
Abstract
Background
Sorafenib is a kinase inhibitor that is used as a first-line therapy in advanced hepatocellular carcinoma (HCC) patients. However, the existence of sorafenib resistance has limited its therapeutic effect. Through RNA sequencing, we demonstrated that miR-138-1-3p was downregulated in sorafenib resistant HCC cell lines. This study aimed to investigate the role of miR-138-1-3p in sorafenib resistance of HCC.
Methods
In this study, quantitative real-time PCR (qPCR) and Western Blot were utilized to detect the levels of PAK5 in sorafenib-resistant HCC cells and parental cells. The biological functions of miR-138-1-3p and PAK5 in sorafenib-resistant cells and their parental cells were explored by cell viability assays and flow cytometric analyses. The mechanisms for the involvement of PAK5 were examined via co-immunoprecipitation (co-IP), immunofluorescence, dual luciferase reporter assay and chromatin immunoprecipitation (ChIP). The effects of miR-138-1-3p and PAK5 on HCC sorafenib resistant characteristics were investigated by a xenotransplantation model.
Results
We detected significant down-regulation of miR-138-1-3p and up-regulation of PAK5 in sorafenib-resistance HCC cell lines. Mechanistic studies revealed that miR-138-1-3p reduced the protein expression of PAK5 by directly targeting the 3′-UTR of PAK5 mRNA. In addition, we verified that PAK5 enhanced the phosphorylation and nuclear translocation of β-catenin that increased the transcriptional activity of a multidrug resistance protein ABCB1.
Conclusions
PAK5 contributed to the sorafenib resistant characteristics of HCC via β-catenin/ABCB1 signaling pathway. Our findings identified the correlation between miR-138-1-3p and PAK5 and the molecular mechanisms of PAK5-mediated sorafenib resistance in HCC, which provided a potential therapeutic target in advanced HCC patients.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference73 articles.
1. Ankita M, Harpreet K, Sakshi S, Shruthi K, Ramanpreet K, Anuradha C. Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line. Clin Mol Hepatol. 2020;26(1):45–53. https://doi.org/10.3350/cmh.2019.0031. 2. Jian-Feng Z, Shaozhong H, Zongyue Z, Xinqi G, Lei C, Guangying Q. PMPCB silencing sensitizes HCC tumor cells to sorafenib therapy. Mol Ther. 2019;27(10):1784–95. https://doi.org/10.1016/j.ymthe.2019.06.014. 3. Llovet JM, Thomas D, Jean-Luc R, Eveline B, Masatoshi K, Charissa C, Yoon-Koo K, Eric A, Ho-Yeong L, Valerie B, Philippe M, Laetitia F, Deng-Yn L, Jordi B, Poon RT, Morris S, Jean-Frédéric B, Finn RS, Won-Young T, Yee C, Rana E, David L, Ian W, Joong-Won P. Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. J Clin Oncol. 2013;31(28):3509–16. https://doi.org/10.1200/JCO.2012.47.3009. 4. Weiwei T, Ziyi C, Wenling Z, Ye C, Betty Z, Fan W, Qian W, Shouju W, Dawei R, Reiter FP, De Toni EN, Xuehao W. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https://doi.org/10.1038/s41392-020-0187-x. 5. Man T, Noélia C, Lei Z, Luk ST, Kau PW, Stella C, Ngan ES, Chung-Mau L, Kwan M, Jin D, Lee TK, Stephanie M. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. J Hepatol. 2018;69(4):826–39. https://doi.org/10.1016/j.jhep.2018.05.034.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|